<SEC-DOCUMENT>0001974158-23-000019.txt : 20230605
<SEC-HEADER>0001974158-23-000019.hdr.sgml : 20230605
<ACCEPTANCE-DATETIME>20230605172210
ACCESSION NUMBER:		0001974158-23-000019
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230605
DATE AS OF CHANGE:		20230605

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ventyx Biosciences, Inc.
		CENTRAL INDEX KEY:			0001851194
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				832996852
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-40928
		FILM NUMBER:		23993886

	BUSINESS ADDRESS:	
		STREET 1:		662 ENCINITAS BLVD., STE. 250
		CITY:			ENCINITAS
		STATE:			CA
		ZIP:			92024
		BUSINESS PHONE:		(858) 945-2393

	MAIL ADDRESS:	
		STREET 1:		662 ENCINITAS BLVD., STE. 250
		CITY:			ENCINITAS
		STATE:			CA
		ZIP:			92024

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			New Science Ventures Fund III (Offshore), L.P.
		CENTRAL INDEX KEY:			0001610749
		IRS NUMBER:				465648714
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		610 FIFTH AVENUE, SUITE 305
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
		BUSINESS PHONE:		212-661-3498

	MAIL ADDRESS:	
		STREET 1:		610 FIFTH AVENUE, SUITE 305
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10020
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001610749</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001851194</issuerCik>
      <issuerName>Ventyx Biosciences, Inc.</issuerName>
      <secFileNumber>001-40928</secFileNumber>
      <issuerAddress>
        <com:street1>662 ENCINITAS BLVD., STE. 250</com:street1>
        <com:city>ENCINITAS</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92024</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>7605934832</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>New Science Ventures Fund III (Offshore), L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Jefferies LLC</name>
        <address>
          <com:street1>520 Madison Ave, 4th Fl</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10022</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2443</noOfUnitsSold>
      <aggregateMarketValue>80013.14</aggregateMarketValue>
      <noOfUnitsOutstanding>58350000</noOfUnitsOutstanding>
      <approxSaleDate>06/05/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <acquiredDate>07/30/2015</acquiredDate>
      <natureOfAcquisitionTransaction>Pre IPO Investment</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Ventyx Biosciences</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2443</amountOfSecuritiesAcquired>
      <paymentDate>07/30/2015</paymentDate>
      <natureOfPayment>N/A</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NSV Partners III, LP</name>
        <address>
          <com:street1>500 W. Putnam Ave, Suite 400</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>04/12/2023</saleDate>
      <amountOfSecuritiesSold>28554</amountOfSecuritiesSold>
      <grossProceeds>856864.99</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NSV Partners III, LP</name>
        <address>
          <com:street1>500 W. Putnam Ave, Suite 400</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>04/13/2023</saleDate>
      <amountOfSecuritiesSold>71446</amountOfSecuritiesSold>
      <grossProceeds>2165797.61</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NSV Partners III, LP</name>
        <address>
          <com:street1>500 W. Putnam Ave, Suite 400</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>04/21/2023</saleDate>
      <amountOfSecuritiesSold>8642</amountOfSecuritiesSold>
      <grossProceeds>324177.93</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NSV Partners III, LP</name>
        <address>
          <com:street1>500 W. Putnam Ave, Suite 400</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>04/24/2023</saleDate>
      <amountOfSecuritiesSold>90565</amountOfSecuritiesSold>
      <grossProceeds>3498982.40</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>NSV Partners III, LP</name>
        <address>
          <com:street1>500 W. Putnam Ave, Suite 400</com:street1>
          <com:city>Greenwich</com:city>
          <com:stateOrCountry>CT</com:stateOrCountry>
          <com:zipCode>06830</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common</securitiesClassTitle>
      <saleDate>04/25/2023</saleDate>
      <amountOfSecuritiesSold>793</amountOfSecuritiesSold>
      <grossProceeds>30831.84</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>06/05/2023</noticeDate>
      <signature>Thomas Lavin</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
